Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1981 Nov 15;125(10):1098–1100.

Some ethical problems in Huntington's chorea.

T L Perry
PMCID: PMC1862654  PMID: 6459840

Full text

PDF
1098

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
  2. Butterfield D. A., Oeswein J. Q., Markesbery W. R. Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease. Nature. 1977 Jun 2;267(5610):453–455. doi: 10.1038/267453a0. [DOI] [PubMed] [Google Scholar]
  3. Gale J. S., Bird E. D., Spoke E. G., Ivejsen L. L., Jessel T. Human brain substance P: distribution in controls and Huntington's chorea. J Neurochem. 1978 Mar;30(3):633–634. doi: 10.1111/j.1471-4159.1978.tb07818.x. [DOI] [PubMed] [Google Scholar]
  4. Goetz I., Roberts E., Comings D. E. Fibroblasts in Huntington's disease. N Engl J Med. 1975 Dec 11;293(24):1225–1227. doi: 10.1056/NEJM197512112932403. [DOI] [PubMed] [Google Scholar]
  5. Gray P. N., May P. C., Mundy L., Elkins J. L-Glutamate toxicity in Huntington's disease fibroblasts. Biochem Biophys Res Commun. 1980 Jul 31;95(2):707–714. doi: 10.1016/0006-291x(80)90843-8. [DOI] [PubMed] [Google Scholar]
  6. Harper P. S., Walker D. A., Tyler A., Newcombe R. G., Davies K. Huntington's chorea. The basis for long-term prevention. Lancet. 1979 Aug 18;2(8138):346–349. doi: 10.1016/s0140-6736(79)90356-8. [DOI] [PubMed] [Google Scholar]
  7. Ingelfinger F. J. Arrogance. N Engl J Med. 1980 Dec 25;303(26):1507–1511. doi: 10.1056/NEJM198012253032604. [DOI] [PubMed] [Google Scholar]
  8. Klawans H. L., Goetz C. G., Paulson G. W., Barbeau A. Levodopa and presymptomatic detection of Huntington's disease--eight-year follow-up. N Engl J Med. 1980 May 8;302(19):1090–1090. doi: 10.1056/NEJM198005083021916. [DOI] [PubMed] [Google Scholar]
  9. Manyam N. V., Katz L., Hare T. A., Gerber J. C., 3rd, Grossman M. H. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Arch Neurol. 1980 Jun;37(6):352–355. doi: 10.1001/archneur.1980.00500550054006. [DOI] [PubMed] [Google Scholar]
  10. Moshell A. N., Tarone R. E., Barrett S. F., Robbins J. H. Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis. Lancet. 1980 Jan 5;1(8158):9–11. doi: 10.1016/s0140-6736(80)90550-4. [DOI] [PubMed] [Google Scholar]
  11. Noronha A. B., Roos R. P., Antel J. P., Arnason B. G. Huntington's disease: abnormality of lymphocyte capping. Ann Neurol. 1979 Nov;6(5):447–450. doi: 10.1002/ana.410060512. [DOI] [PubMed] [Google Scholar]
  12. Perry T. L., Hansen S., Kloster M. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med. 1973 Feb 15;288(7):337–342. doi: 10.1056/NEJM197302152880703. [DOI] [PubMed] [Google Scholar]
  13. Perry T. L., Wright J. M., Hansen S., Allan B. M., Baird P. A., MacLeod P. M. Failure of aminooxyacetic acid therapy in Huntington disease. Neurology. 1980 Jul;30(7 Pt 1):772–775. doi: 10.1212/wnl.30.7.772. [DOI] [PubMed] [Google Scholar]
  14. Perry T. L., Wright J. M., Hansen S., MacLeod P. M. Isoniazid therapy of Huntington disease. Neurology. 1979 Mar;29(3):370–375. doi: 10.1212/wnl.29.3.370. [DOI] [PubMed] [Google Scholar]
  15. Pettegrew J. W., Nichols J. S., Stewart R. M. Fluorescence spectroscopy on Huntington's fibroblasts. J Neurochem. 1979 Oct;33(4):905–911. doi: 10.1111/j.1471-4159.1979.tb09920.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES